Review Ascites-Derived Organoids: Emerging Models for Drug Resistance and Personalized Therapy Full text PDF
Research Paper Integrative Multi-Cohort and Single-Cell Analyses Identify KIF11 as a Prognostic and Immune-Cold Marker in Lung Adenocarcinoma Full text PDF
Research Paper Co-targeting Aurora Kinase A and DNA Damage Response Pathways Enhances Apoptotic Cell Death in Cholangiocarcinoma Cells Full text PDF
Review Lung Cancer Evolves as an Ecosystem from Niche Dysregulation to Metastasis and Treatment Resistance Full text PDF
Review The Roles of Vitamins in Cancer Initiation, Progression, and Therapy: Clinical Evidence, Molecular Mechanisms, and Precision Translation Full text PDF
Research Paper Real-World Experience with Neoadjuvant Treatment for Stage I-III Non-Small Cell Lung Cancer: A Single-Center Cohort Study and TriNetX database Full text PDF
Issue 11; 2026
Indexed in PubMed and SCI expanded; full texts in Europe PMC. ...
Breakthroughs in immune checkpoint inhibitors (ICIs) are rapidly shifting the treatment paradigm for resectable non-small cell lung cancer (NSCLC) toward neoadjuvant and perioperative strategies. To assess the real-world efficacy and broad applicability of neoadjuvant immunotherapy, we analyzed 62 patients who received neoadjuvant systemic therapy followed by surgery at Taichung Veterans General Hospital between November 2019 and April 2025, dividing ...
Lung Cancer Evolves as an Ecosystem from Niche Dysregulation to Metastasis and Treatment Resistance
The clinical heterogeneity of lung cancer, the continuing divergence between primary and metastatic lesions, and relapse after treatment cannot be fully explained by a linear model of cancer-cell-intrinsic mutation. Most tumor-microenvironment reviews describe a local system at a single time point and rarely follow lung cancer across disease stages and organs. Here, we use the ecosystem as a unifying framework to examine how genetic change, tissue ...